(1-(3-(9H-carbazol-4-yloxy)-2-hydroxypropyl)piperidin-4-yl)(4-methoxyphenyl)methanone

ID: ALA1082828

PubChem CID: 46889853

Max Phase: Preclinical

Molecular Formula: C28H30N2O4

Molecular Weight: 458.56

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(C(=O)C2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1

Standard InChI:  InChI=1S/C28H30N2O4/c1-33-22-11-9-19(10-12-22)28(32)20-13-15-30(16-14-20)17-21(31)18-34-26-8-4-7-25-27(26)23-5-2-3-6-24(23)29-25/h2-12,20-21,29,31H,13-18H2,1H3

Standard InChI Key:  NRJOGQSIFAHXIH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   -2.9833   -2.0775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2670   -1.6642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2698   -0.8337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5569   -0.4186    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8410   -0.8283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1282   -0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5877   -0.8230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1313    0.4117    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3007   -0.4079    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0164   -0.8207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7271   -0.4092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7283    0.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0125    0.8281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2956    0.4148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4428    0.8286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6980   -1.6646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7051   -0.8347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9892   -0.4222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3187   -0.2813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9821    0.4733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1635    0.3863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6806    1.0507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0153    1.8026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8375    1.8860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3167    1.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1571    0.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1551   -0.4094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8687   -0.8217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5840   -0.4093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5814    0.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8673    0.8286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4428    1.6535    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2990   -0.8208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3001   -1.6457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  7  1  0
 17 18  1  0
  3 18  2  0
  6  8  1  0
 18 21  1  0
 20 19  1  0
 19 17  1  0
  7  9  1  0
  9 10  1  0
 20 21  2  0
  3  4  1  0
 21 22  1  0
  1  2  2  0
 22 23  2  0
  4  5  1  0
 23 24  1  0
 16  1  1  0
 24 25  2  0
 25 20  1  0
  5  6  1  0
 15 26  1  0
  9 14  1  0
 26 27  2  0
 10 11  1  0
 27 28  1  0
 11 12  1  0
 28 29  2  0
 12 13  1  0
 29 30  1  0
 13 14  1  0
 30 31  2  0
 31 26  1  0
  2  3  1  0
 15 32  2  0
 12 15  1  0
 29 33  1  0
 16 17  2  0
 33 34  1  0
M  END

Associated Targets(Human)

ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 458.56Molecular Weight (Monoisotopic): 458.2206AlogP: 4.66#Rotatable Bonds: 8
Polar Surface Area: 74.79Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.89CX LogP: 3.99CX LogD: 3.38
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.38Np Likeness Score: -0.55

References

1. Tasler S, Baumgartner R, Aschenbrenner A, Ammendola A, Wolf K, Wieber T, Schachtner J, Blisse M, Quotschalla U, Ney P..  (2010)  A vHTS approach for the identification of beta-adrenoceptor ligands.,  20  (11): [PMID:20434333] [10.1016/j.bmcl.2010.04.009]

Source